SubscribeIn the News

RESHAPE MEDICAL UNVEILS US PIVOTAL TRIAL RESULTS FOR NON-SURGICAL WEIGHT LOSS PROCEDURE FEATURED IN TOP 10 PAPER AT OBESITY WEEK 2014

Tuesday, November 4th, 2014 | Healthcare

VIRENT: THE NEW ALCHEMY? COMPANY MAKES JET FUEL AND PLASTIC SODA BOTTLES OUT OF FARM WASTES

Tuesday, November 4th, 2014 | Clean Tech

VIRENT AND THE PLANTPET TECHNOLOGY COLLABORATIVE (PTC) SIGN EXPRESSION OF INTEREST TO ACCESS COMMERCIAL QUANTITIES OF VIRENT’S BIOFORMPX PARAXYLENE

Thursday, October 30th, 2014 | Clean Tech

CHROMATIN, INC. RECEIVES GOVERNOR’S EXPORT AWARD

Tuesday, October 28th, 2014 | Clean Tech

JUVENTAS THERAPEUTICS STRENGTHENS MANAGEMENT TEAM WITH NEW SENIOR VICE PRESIDENT OF FINANCE AND OPERATIONS

Tuesday, October 28th, 2014 | Healthcare

AKEBIA ANNOUNCES POSITIVE TOP-LINE RESULTS FROM ITS PHASE 2B STUDY OF AKB-6548 IN NON-DIALYSIS PATIENTS WITH ANEMIA RELATED TO CHRONIC KIDNEY DISEASE

Monday, October 27th, 2014 | Healthcare

VENTURE INVESTORS FOUNDER ROGER GANSER ELECTED TO STATE’S INVESTOR HALL OF FAME

Wednesday, October 22nd, 2014 | Venture Investors

NEUWAVE MEDICAL CORRALS $4.8M FOR TUMOR-ZAPPING TECH

Wednesday, October 15th, 2014 | Healthcare

DELTANOID’S DP001 (2MD) PHARMACEUTICAL DEMONSTRATED SAFE AND EFFECTIVE IN KIDNEY FAILURE PATIENTS ON DIALYSIS

Tuesday, October 14th, 2014 | Healthcare

NANOBIO TO PRESENT DATA DEMONSTRATING THE POTENTIAL FOR ITS INTRANASAL VACCINE TO PROTECT AGAINST GENITAL HERPES INFECTION

Wednesday, October 8th, 2014 | Healthcare

HISTOSONICS: BLAZING NEW TRAILS IN MEDICINE

Tuesday, October 7th, 2014 | Healthcare

RESHAPE MEDICAL – 2014 FIERCE 15

Wednesday, October 1st, 2014 | Healthcare

VIRENT HIRES EDGAR STEENWINKEL TO LEAD TECHNOLOGY DEVELOPMENT EFFORTS

Tuesday, September 30th, 2014 | Clean Tech

THALCHEMY: A “SMART” MOVE FOR ELECTRONICS

Saturday, September 27th, 2014 | Technology

AKEBIA ANNOUNCES DOSING OF FIRST PATIENT IN PHASE 2 STUDY OF AKB-6548 IN PATIENTS WITH ANEMIA RELATED TO CHRONIC KIDNEY DISEASE UNDERGOING DIALYSIS

Thursday, September 25th, 2014 | Healthcare

ALFALIGHT RECEIVES $3.7M CONTRACT TO DELIVER TECHNOLOGY FOR THAAD MISSILE DEFENSE SYSTEM

Tuesday, September 23rd, 2014 | Technology

TISSUE REGENERATION SYSTEMS: STARTUP USES 3D PRINTING TECH TO CREATE ALTERNATIVE TO BONE GRAFTS

Tuesday, September 16th, 2014 | Healthcare

AKEBIA THERAPEUTICS APPOINTS RONALD C. RENAUD JR. TO ITS BOARD OF DIRECTORS

Monday, September 15th, 2014 | Healthcare

VIRENT TO EXPAND DEMO PLANT CAPABILITIES TO SCALE PLANT-BASED PARAXYLENE

Monday, September 8th, 2014 | Clean Tech

CELLECTAR & MVI: TWO MADISON BIOTECHS TO ADVANCE WITH DRUG TRIALS; A MEDICAL DEVICE COMPANY RECEIVES FUNDS

Saturday, September 6th, 2014 | Healthcare

CELLECTAR BIOSCIENCES ANNOUNCES ACCEPTANCE OF INVESTIGATIONAL NEW DRUG APPLICATION TO EVALUATE I-131-CLR1404 IN CLINICAL TRIALS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA

Thursday, September 4th, 2014 | Healthcare

AERPIO THERAPEUTICS ANNOUNCES PUBLICATION OF PRECLINICAL DATA ON AKB-9778 FOR COMMON EYE DISEASES

Tuesday, September 2nd, 2014 | Healthcare

RESHAPE MEDICAL ANNOUNCES NEW DATA SHOWING CLINICALLY SIGNIFICANT WEIGHT LOSS WITH THE RESHAPE PROCEDURE IN EU COMMERCIAL USE

Thursday, August 28th, 2014 | Healthcare

RESHAPE TARGETS U.S. APPROVAL AS EU STUDY SHOWS MAJOR WEIGHT LOSS

Thursday, August 28th, 2014 | Healthcare

MVI VACCINE TO BE USED IN CLINICAL TRIAL OF A NEW COMBINATION APPROACH TO IMMUNOTHERAPY FUNDED BY THE PROSTATE CANCER FOUNDATION AND THE MOVEMBER FOUNDATION

Wednesday, August 27th, 2014 | Healthcare

TISSUE REGENERATION SYSTEMS NABS $4.6M TO IMPROVE FACIAL SURGERIES

Friday, August 22nd, 2014 | Healthcare

TISSUE REGENERATION SYSTEMS TO COLLABORATE WITH J&J, DEPUY SYNTHES

Thursday, August 21st, 2014 | Healthcare

CELLERATION ANNOUNCES NEXT GENERATION ULTRAMIST SYSTEM RECEIVES FDA CLEARANCE

Wednesday, August 20th, 2014 | Healthcare

CELLECTAR BIOSCIENCES ANNOUNCES CLOSING OF PUBLIC OFFERING AND PARTIAL EXERCISE OF UNDERWRITER’S OVER-ALLOTMENT OPTION

Wednesday, August 20th, 2014 | Healthcare

MADISON VACCINES RIDES IMMUNOTHERAPY WAVE WITH EARLY-STAGE PROSTATE DRUG

Monday, August 18th, 2014 | Healthcare

JUVENTAS THERAPEUTICS COMPLETES ENROLLMENT OF PHASE I/II RETRO-HF TRIAL AND DEMONSTRATES SAFETY FOR RETROGRADE INFUSION OF JVS-100 IN PATIENTS WITH HEART FAILURE

Tuesday, August 12th, 2014 | Healthcare

VIRENT RECEIVES EPA REGISTRATION FOR ITS BIOFORM GASOLINE

Tuesday, August 12th, 2014 | Clean Tech

NEUROVANCE COMPLETES ENROLLMENT IN HUMAN ABUSE LIABILITY STUDY FOR CENTANAFADINE (FORMERLY CALLED EB-1020) FOR ADULT ADHD

Thursday, August 7th, 2014 | Healthcare

AKEBIA THERAPEUTICS ANNOUNCES EXPANSION OF MANAGEMENT TEAM

Wednesday, August 6th, 2014 | Healthcare

NEUROVANCE APPOINTS BRIGITTE ROBERTSON, MD, VICE PRESIDENT, CLINICAL DEVELOPMENT

Tuesday, August 5th, 2014 | Healthcare

CHROMATIN: PACIFIC ETHANOL AWARDED $3 MILLION GRANT TO SUPPORT SORGHUM FEEDSTOCK PROGRAM

Monday, July 28th, 2014 | Clean Tech

CHROMATIN, INC. ACQUIRES SORGHUM PRODUCTION AND SUPPLY COMPANY, PRODUCTION SEEDS PLUS, INC.

Wednesday, July 23rd, 2014 | Clean Tech

JUVENTAS THERAPEUTICS STRENGTHENS LEADERSHIP TEAM BY ADDING TWO INDUSTRY VETERANS

Wednesday, July 23rd, 2014 | Healthcare

AKEBIA THERAPEUTICS APPOINTS MICHAEL CLAYMAN, M.D. AND MAXINE GOWEN, PH.D. TO ITS BOARD OF DIRECTORS

Thursday, July 17th, 2014 | Healthcare

NETSOCKET ENTERS STRATEGIC PARTNERSHIP WITH SOLUTION PROVIDER CHUANHOW TECH

Thursday, July 10th, 2014 | Technology

CHROMATIN, INC. SECURES $12.5 MILLION CREDIT FACILITY WITH THE PRIVATEBANK

Wednesday, July 9th, 2014 | Clean Tech

NETSOCKET LAUNCHES NETSOCKET VIRTUAL PARTNER PROGRAM FOR TECHNOLOGY PARTNERS

Wednesday, July 9th, 2014 | Technology

RESHAPE MEDICAL SUBMITS PMA APPLICATION TO FDA FOR NON-SURGICAL WEIGHT LOSS DEVICE

Tuesday, July 1st, 2014 | Healthcare

AKEBIA THERAPEUTICS ADDED TO RUSSELL 3000, RUSSELL 2000 AND RUSSELL GLOBAL INDEXES

Monday, June 30th, 2014 | Healthcare

TRS: JOHNSON & JOHNSON PLANS TO DEVELOP A LINE OF 3-D PRINTED RECONSTRUCTIVE IMPLANTS

Thursday, June 26th, 2014 | Healthcare

CHROMATIN AND ACI LAUNCH NEW SORGHUM PRODUCTS IN ALGERIA

Wednesday, June 25th, 2014 | Clean Tech

THALCHEMY RAISES SEED FUNDS TO DEVELOP ALWAYS-ON SENSOR TECHNOLOGY

Wednesday, June 25th, 2014 | Technology

MADISON VACCINES INCORPORATED ANNOUNCES EXPANSION OF A PHASE 2 CLINICAL TRIAL FOR MVI-816, ITS LEAD DNA VACCINE FOR PROSTATE CANCER

Monday, June 23rd, 2014 | Healthcare

TRS: JOHNSON & JOHNSON INNOVATION CATALYZES NEW AND EXCITING SCIENCE AND TECHNOLOGY IN PARMACEUTICAL, MEDICAL DEVICE, DIAGNOSTIC AND CONSUMER HEALTH SPACES

Thursday, June 19th, 2014 | Healthcare

CHROMATIN: THE MOLECULAR BIOLOGIST WHO WOULD FEED THE WORLD SORGHUM

Saturday, June 14th, 2014 | Clean Tech

ALFALIGHT RECEIVES $49M IDIQ CONTRACT FOR DELIVERY OF OCULAR INTERRUPTION LASER SYSTEM TO U.S. MARINE CORP

Tuesday, June 10th, 2014 | Technology

NEUMODX AND JEFF WILLIAMS CAPITALIZE ON LESSONS LEARNED AT HANDYLAB

Tuesday, June 10th, 2014 | Healthcare

NETSOCKET ROLLS OUT NEW SUITE OF VIRTUALIZED APPLICATIONS ENABLING MSPS TO GROW REVENUE AND DELIVER PROFITABLE NEW MANAGED SERVICES

Tuesday, June 3rd, 2014 | Technology

ALFALIGHT RECEIVES $49M IDIQ CONTRACT FOR DELIVERY OF OCULAR INTERRUPTION LASER SYSTEM TO US MARINE CORPS

Thursday, May 29th, 2014 | Technology

CELLECTAR BIOSCIENCES APPOINTS CHAD J. KOLEAN CHIEF FINANCIAL OFFICER

Thursday, May 29th, 2014 | Healthcare

LOCAL BIOTECH’S HEART FAILURE TREATMENT SHOWS PROMISE – JUVENTAS TO LAUNCH PHASE 3 STUDY NEXT YEAR

Wednesday, May 28th, 2014 | Healthcare

AKEBIA AIMS BIG WITH POTENTIAL DRUG FOR ANEMIA DUE TO CHRONIC KIDNEY DISEASE

Tuesday, May 27th, 2014 | Healthcare

HISTOSONICS NEARS CLOSE OF $14.2M FUNDING FOR NON-INVASIVE ABLATION

Tuesday, May 20th, 2014 | Healthcare

MADISON VACCINES ANNOUNCES THE APPOINTMENT OF MICHAEL RICHMAN TO ITS BOARD OF DIRECTORS

Wednesday, May 14th, 2014 | Healthcare

NEUWAVE MEDICAL, INC. NAMES DANIEL J. SULLIVAN AS PRESIDENT AND CEO

Monday, May 12th, 2014 | Healthcare

NEUROVANCE’S EB-1020 SR FOR ADULT ADHD SHOWS STIULANT-LIKE EFFICACY IN PHASE 2A TRIAL

Thursday, May 8th, 2014 | Healthcare

CELLECTAR BIOSCIENCES ANNOUNCES RECEIPT OF ORPHAN DESIGNATION OF I-124-CLR1404 AS DIAGNOSTIC FOR THE MANAGEMENT OF GLIOMA FROM U.S. FOOD AND DRUG ADMINISTRATION

Monday, May 5th, 2014 | Healthcare

AERPIO THERAPEUTICS PRESENTS FULL RESULTS FROM PHASE 1B/2A STUDY OF AKB-9778 FOR THE TREATMENT OF DIABETIC MACULAR EDEMA AT ARVO ANNUAL MEETING

Monday, May 5th, 2014 | Healthcare

AERPIO THERAPEUTICS CLOSES $22M FINANCING

Wednesday, April 23rd, 2014 | Healthcare

AKEBIA SOARS WITH ANALYSTS’ HIGH HOPES

Monday, April 14th, 2014 | Healthcare

NEUROVANCE CLOSES $6.3M FINANCING TO SUPPORT FURTHER DEVELOPMENT OF EB-1020 SR IN ADULT ADHD

Thursday, April 3rd, 2014 | Healthcare

CELLECTAR BIOSCIENCES NAMES NEW PRESIDENT, CEO

Wednesday, April 2nd, 2014 | Healthcare

RESHAPE DUO BALLOON OFFERS BARIATRIC SURGERY ALTERNATIVE

Tuesday, April 1st, 2014 | Healthcare

UPTO LAUNCHES A CALENDAR APP FOR THE FOMO GENERATION

Thursday, March 27th, 2014 | Technology

UPTO INTRODUCES THE CALENDAR OF THE FUTURE

Thursday, March 27th, 2014 | Technology

AKEBIA THERAPEUTICS ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING AND FULL EXERCISE OF UNDERWRITERS’ OPTION TO PURCHASE ADDITIONAL SHARES

Wednesday, March 26th, 2014 | Healthcare

MERCK LICENSES NANOBIO TECHNOLOGY

Wednesday, March 26th, 2014 | Healthcare

NEUMODX ANNOUNCES COMPLETION OF SERIES B FINANCING

Wednesday, March 26th, 2014 | Healthcare

CELLERATION REACHES KEY MILESTONE OF 1 MILLION MIST THERAPY TREATMENTS

Thursday, March 13th, 2014 | Healthcare

ANEMIA BIOTECH AKEBIA THERAPEUTICS SETS TERMS FOR $76 MILLION IPO

Friday, March 7th, 2014 | Healthcare